VOYA INVESTMENT MANAGEMENT LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1068837 ATLANTA, GA

Position in FTRE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,523,894

+$2,379,612 QoQ

Shares Held

259,994

+14.2% QoQ

Ownership

0.273%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 76% None 24%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. FTRE ranks #42 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	TWST	Twist Bioscience Corp	671,866	$69,121,573
4	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
5	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
6	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
7	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
8	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,523,894	259,994	+14.2%	Shares	Defined	2026-08-12
2026-03-31	$2,144,282	227,631	-15.4%	Shares	Defined	2026-05-12
2025-12-31	$4,643,233	269,173	-17.6%	Shares	Defined	2026-02-12
2025-09-30	$2,749,137	326,501	-23.5%	Shares	Defined	2025-10-09
2025-06-30	$2,108,875	426,898	+40.5%	Shares	Defined	2025-08-14
2025-03-31	$2,294,452	303,901	+134.9%	Shares	Defined	2025-06-18
2024-12-31	$2,412,413	129,352	+781.1%	Shares	Defined	2025-05-02
2024-09-30	$293,600	14,680	-37.6%	Shares	Defined	2025-02-07
2024-06-30	$549,446	23,541	+9.5%	Shares	Defined	2025-02-07
2024-03-31	$862,729	21,493	+1.1%	Shares	Defined	2025-02-07
2023-12-31	$742,182	21,266	+17.4%	Shares	Defined	2025-02-07
2023-09-30	$517,850	18,113	—	Shares	Defined	2025-02-07
No filing history on record for this holder in this stock.